Analysis of the Agger nasi cell and frontal sinus ostium sizes using computed tomography of the paranasal sinuses.

UNLABELLED: The Agger nasi cell (ANC) and the frontal sinus ostium (FO) are important structures that can influence the anatomy and physiology of the frontal recess. The aim of this study was to evaluate the presence and size of ANC and the FO and correlate them according to gender, race and among themselves. METHOD: A prospective study with 40 patients who underwent CT of the paranasal sinuses with sagittal reconstruction. MEASUREMENTS: ANC (APAN) anteroposterior diameter, ANC (CCAN) craniocaudal diameter, ANC (LLAN) side-to-side diameter, anteroposterior diameter of the FO (APFO) and side-to-side diameter of the FO (LLFO). RESULTS: Twenty-two patients were male and 18 females, mean age 33.7 years. Most patients were white (45%), followed by browns (32.5%), blacks (20%) and asians (2.5%). The ANC was present in 98.7% of patients. There was statistical difference for APAN on females and LLAN on females and on the total sample. There were no differences for all measurements regarding gender, as well as the race. ANC and FO measurements showed positive correlation, but poor or very poor. CONCLUSION: The prevalence of ANC in our sample was high and did not show a statistically significant difference for most measurements. The correlation between measurements of ANC and the FO was poor or very poor.

Análise das dimensões da célula do Agger nasi e do óstio do seio frontal utilizando tomografia computadorizada de seios paranasais / Analysis of the Agger nasi cell and frontal sinus ostium sizes using computed tomography of the paranasal sinuses

A célula do Agger nasi (CAN) e o óstio do seio frontal (OF) são estruturas importantes que podem influenciar a anatomofisiologia do recesso frontal. OBJETIVO: O objetivo deste trabalho foi avaliar a presença e as dimensões da CAN e do OF e correlacioná-las de acordo com o sexo, raça e entre si. MÉTODO: Estudo prospectivo com 40 pacientes submetidos à tomografia computadorizada de seios paranasais com reconstrução sagital. Foram realizadas as medidas: diâmetro ântero-posterior da CAN (AGAP), diâmetro crânio-caudal da CAN (AGCC), diâmetro látero-lateral da CAN (AGLL), diâmetro ântero-posterior do OF (OFAP) e diâmetro látero-lateral do OF (OFLL). RESULTADOS: Vinte e dois pacientes eram do sexo masculino e 18, do feminino; média de idade de 33,7 anos. A maioria dos pacientes era da raça branca (45%), seguidos pelos da raça parda (32,5%), da raça negra (20%) e da raça amarela. A CAN esteve presente em 98,7% das fossas nasais. Houve diferença estatística para AGAP no sexo feminino e AGLL no sexo feminino e na amostra total. Não houve diferenças para as medidas tanto quanto ao sexo como quanto à raça. As medidas da CAN e do OF apresentaram correlação, mas de maneira ruim ou péssima. CONCLUSÃO: A prevalência da CAN em nossa amostra foi alta e não houve diferença estatisticamente significante para a maioria das medidas realizadas. A correlação das medidas da CAN e do OF foi ruim ou péssima.

The Agger nasi cell (ANC) and the frontal sinus ostium (FO) are important structures that can influence the anatomy and physiology of the frontal recess. The aim of this study was to evaluate the presence and size of ANC and the FO and correlate them according to gender, race and among themselves. METHOD: A prospective study with 40 patients who underwent CT of the paranasal sinuses with sagittal reconstruction. Measurements: ANC (APAN) anteroposterior diameter, ANC (CCAN) craniocaudal diameter, ANC (LLAN) side-to-side diameter, anteroposterior diameter of the FO (APFO) and side-to-side diameter of the FO (LLFO). RESULTS: Twenty-two patients were male and 18 females, mean age 33.7 years. Most patients were white (45%), followed by browns (32.5%), blacks (20%) and asians (2.5%). The ANC was present in 98.7% of patients. There was statistical difference for APAN on females and LLAN on females and on the total sample. There were no differences for all measurements regarding gender, as well as the race. ANC and FO measurements showed positive correlation, but poor or very poor. CONCLUSION: The prevalence of ANC in our sample was high and did not show a statistically significant difference for most measurements. The correlation between measurements of ANC and the FO was poor or very poor.

Insônia em idosos / Insomnia in elderly

Sabe-se que o sono não é simplesmente ausência de vigília nem um processo passivo. É um estado ativo e cíclico, vinculado a controles hormonais, metabólicos, bioquímicos e de temperatura, imprescindíveis à vida. Insônia é a dificuldade ou incapacidade para iniciar ou manter o sono, também pode expressar-se por uma duração demasiadamente curta do sono ou por não ser reparador. A deficiência de sono presente pode originar alterações psíquicas, diminuição do aprendizado e da capacidade laboral; maiores riscos de acidentes de trabalho e trânsito; aumento da taxa de mortalidade por doenças isquêmicas e câncer. A apresentação na população idosa deste evento se caracteriza por ser acompanhada nos dias que a seguem por sonolência excessiva diurna, irritabilidade, cefaleias, confusão mental, alterações cognitivo-comportamentais, dores neuromusculares, sonolência patológica, crises convulsivas e coma.

Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.

UNLABELLED: Acquired middle ear cholesteatoma is a benign keratinizing hyperproliferative squamous epithelial lesion that may result in the destruction of the bone structures surrounding the temporal bone. Recent studies show that variations in cellular production of matrix metalloproteinases (MMPs) and their specific inhibitors (TIMPs) contribute to the pathophysiology of cholesteatoma. OBJECTIVE: This study aims to analyze the use of RNA amplification tests to evaluate the expression of MMP and TIMP isoforms in cholesteatomas and their correlation with disease severity. MATERIALS AND METHODS: This is a prospective study. Nineteen cholesteatoma cases at different stages were selected. RNA collected from biopsy specimens was submitted to reverse transcription polymerase chain reaction (RT-PCR) for semiquantitative amplification of MMP2, MMP3, MMP9, MMP13 and TIMP1. RESULTS: Six cholesteatomas were positive for at least one of the studied genes. Four samples amplified a single gene (MMP2 or MMP13) and two samples amplified three genes (MMP2, TIMP1 and MMP3 or MMP13). No sample amplified MMP9. CONCLUSION: RT-PCR can be used to assess MMP and TIMP gene expression in cholesteatomas despite technical difficulties. Gene expression profiles could not be related to disease severity.

Avaliação da expressão gênica de metaloproteinases de matriz e seus inibidores em colesteatomas por amplificação de ácidos nucleicos / Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR

O colesteatoma adquirido da orelha média é uma lesão epitelial escamosa queratinizante e hiperproliferativa benigna que pode resultar na destruição das estruturas ósseas circunvizinhas do osso temporal. Estudos recentes demonstram que alterações na produção celular de metaloproteinases de matriz (MMPs) e seus inibidores específicos (TIMPs) contribuem para a fisiopatologia do colesteatoma. OBJETIVO: Verificar a aplicabilidade da amplificação de RNA para avaliação da expressão de isoformas de MMPs e TIMPS em colesteatomas para correlação com a agressividade da doença. MATERIAIS E MÉTODOS: Estudo prospectivo. Dezenove casos de colesteatomas em diferentes estágios de evolução foram selecionados. RNA extraído das biópsias foi submetido à transcrição reversa - reação da polimerase em cadeia (RT-PCR) para amplificação semiquantitativa de MMP2, MMP3, MMP9, MMP13 e TIMP1. Resultados: Seis colesteatomas apresentaram reação positiva para pelo menos um dos genes estudados. Quatro amostras amplificaram apenas um gene (MMP2 ou MM13) e duas amostras amplificaram três genes (MMP2, TIMP1 e MMP3 ou MMP13). Nenhuma amostra amplificou MMP9. CONCLUSÃO: A avaliação da expressão gênica de MMPs e TIMPs em colesteatomas pode ser realizada por RT-PCR, apesar de dificuldades técnicas. Não foi possível realizar associação entre o perfil de expressão gênica e a agressividade da doença.

Acquired middle ear cholesteatoma is a benign keratinizing hyperproliferative squamous epithelial lesion that may result in the destruction of the bone structures surrounding the temporal bone. Recent studies show that variations in cellular production of matrix metalloproteinases (MMPs) and their specific inhibitors (TIMPs) contribute to the pathophysiology of cholesteatoma. OBJECTIVE: This study aims to analyze the use of RNA amplification tests to evaluate the expression of MMP and TIMP isoforms in cholesteatomas and their correlation with disease severity. MATERIALS AND METHODS: This is a prospective study. Nineteen cholesteatoma cases at different stages were selected. RNA collected from biopsy specimens was submitted to reverse transcription polymerase chain reaction (RT-PCR) for semiquantitative amplification of MMP2, MMP3, MMP9, MMP13 and TIMP1. RESULTS: Six cholesteatomas were positive for at least one of the studied genes. Four samples amplified a single gene (MMP2 or MMP13) and two samples amplified three genes (MMP2, TIMP1 and MMP3 or MMP13). No sample amplified MMP9. CONCLUSION: RT-PCR can be used to assess MMP and TIMP gene expression in cholesteatomas despite technical difficulties. Gene expression profiles could not be related to disease severity.

Anosmia congênita associada à hipospádia: relato de caso / Congenital anosmia associated with hypospadia: a case report

Introdução: A incidência de distúrbios olfatórios nos Estados Unidos da América é de cerca de 200 mil pacientes por ano, sendo as doenças sinusais as causas mais comuns. A anosmia congênita é rara e pode ocorrer como parte de uma síndrome ou como anosmia isolada. O objetivo deste trabalho é relatar um caso raro de anosmia congênita associada à hipospádia. Descrição do caso: Paciente masculino com 20 anos de idade e quadro de anosmia congênita, apresentando gustação e sensibilidade olfatória para odores irritantes preservadas. Refere hipospádia operada aos 13 anos de idade. Negava antecedentes familiares de anosmia. Apresentava exame otorrinolaringológico e nasofibroscopia sem alterações. Ao exame neurológico constatou-se anosmia pelo Cross Culture Smell Test. Ao exame geniturinário, apresentava orifício fistuloso em face ventral de terço médio do pênis, testículos tópicos e de tamanho normal, e desenvolvimento normal dos caracteres sexuais secundários. Observou-se, na tomografia computadorizada dos seios paranasais, presença de concha média bolhosa à esquerda. A ressonância magnética apresentava-se dentro dos padrões de normalidade. Uma análise hormonal foi realizada, cujos resultados foram: hormônio luteinizante de 5,02 mUI/mL, Hormônio folículo-estimulante de 0,8 mUI/mL e testosterona total de 887 ng/dL. Discussão: O relato deste caso é importante pela existência de apenas dois casos relatados na literatura de anosmia congênita associada à hipospádia. O relato de um novo caso e da associação da anosmia com outras anormalidades, como a hipospádia, pode auxiliar na aquisição de novos conhecimentos sobre o assunto e a despertar interesse na descoberta de algum fator etiológico comum às duas anormalidades.

Introduction: The incidence of olfactory disorders in the United States is approximately 200,000 patients per year. Sinus diseases are the most common causes. The congenital anosmia is rare and may occur as part of a syndrome or isolated. The purpose of this paper is to report a case of congenital anosmia associated with hypospadia. Case report: Male, 20 years old, reporting congenital anosmia. The taste and olfactory perception for irritant odors were preserved. He was submitted to hypospadia repair surgery at the age of 13 years old. Family history of anosmia was negative. Otolaryngologyc exam and nasofibroscopy were normal. In the neurologic exam, anosmia was determined by Cross Culture Smell Test. Genitourinary exam showed: fistular orificium in ventral face of medium third section of penis, topic and normal size testicles and full development of secondary sexual characters. On computed tomography of paranasal sinuses, a concha bullosa was observed on the left. The magnetic resonance was normal. Hormonal tests: LH 5.02 mUI/mL, FSH 0.8 mUI/mL and total testosterone 887 ng/dL. Discussion: This case report is important because there are only two cases reported in the literature about congenital anosmia associated with hypospadia. The report of a new case and the association of anosmia with others abnormalities such as hypospadia may lead to additional knowledge about the subject and may raise interest on the discovery of common etiological factors of these abnormalities (anosmia and hypospadia).

Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis.

UNLABELLED: Allergic rhinitis affects 10-30% of the population, negatively impacting one's quality of life and productivity. It has been associated with sinusitis, otitis media, sleep disorders, and asthma. Rupatadine is a second generation antihistamine with increased affinity to histamine receptor H1; it is also a potent PAF (platelet-activating factor) antagonist. It starts acting quite quickly, offers long lasting effect, and reduces the chronic effects of rhinitis. AIM: this study aims to assess the efficacy and safety of rupatadine in the treatment of persistent allergic rhinitis. MATERIALS AND METHOD: this is a multi-centric open prospective study. This study included 241 patients from 13 centers in Brazil and was held between October of 2004 and August of 2005. Signs and symptoms of rhinitis and tolerance to medication were analyzed after one and two weeks of treatment. RESULTS: reduction on general scores from 8.65 to 3.21 on week 2 (p<0.001). All signs and symptoms improved significantly in the first day of treatment (p<0.001), except for nasal congestion and secretion, which improved from the second day of treatment (p<0.001). Adverse events occurred in 19.9% of the cases, 27.7% on week 1. CONCLUSION: rupatadine effectively controls persistent allergic rhinitis; it is safe and presents low incidence of side effects.

Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis / Estudo futura: avaliação da eficácia e segurança do fumarato de rupatadina no tratamento da rinite alérgica persistente

Allergic rhinitis affects 10-30 percent of the population, negatively impacting one's quality of life and productivity. It has been associated with sinusitis, otitis media, sleep disorders, and asthma. Rupatadine is a second generation antihistamine with increased affinity to histamine receptor H1; it is also a potent PAF (platelet-activating factor) antagonist. It starts acting quite quickly, offers long lasting effect, and reduces the chronic effects of rhinitis. AIM: this study aims to assess the efficacy and safety of rupatadine in the treatment of persistent allergic rhinitis. MATERIALS AND METHOD: this is a multi-centric open prospective study. This study included 241 patients from 13 centers in Brazil and was held between October of 2004 and August of 2005. Signs and symptoms of rhinitis and tolerance to medication were analyzed after one and two weeks of treatment. RESULTS: reduction on general scores from 8.65 to 3.21 on week 2 (p<0.001). All signs and symptoms improved significantly in the first day of treatment (p<0.001), except for nasal congestion and secretion, which improved from the second day of treatment (p<0.001). Adverse events occurred in 19.9 percent of the cases, 27.7 percent on week 1. CONCLUSION: rupatadine effectively controls persistent allergic rhinitis; it is safe and presents low incidence of side effects.

A rinite alérgica acomete 10 a 30 por cento da população, interferindo na qualidade de vida e na capacidade produtiva. Está associada à sinusite, otite, roncopatias e asma. A Rupatadina é um anti-histamínico de segunda geração, com elevada afinidade ao receptor histamínico H1 e potente inibição do fator ativador plaquetário (PAF). Tem rápido início de ação, longa duração e reduz os efeitos crônicos da rinite. OBJETIVO: Avaliar a eficácia e segurança da rupatadina no tratamento da rinite alérgica persistente. MATERIAL E MÉTODO: Estudo multicêntrico, aberto, prospectivo. Foram selecionados 241 pacientes em 13 centros no Brasil durante o período de outubro de 2004 a agosto de 2005. Foram analisados os sinais e sintomas da rinite e a tolerabilidade após 1 e 2 semanas. RESULTADOS: Redução do escore geral de 8,65 para 3,21 na semana 2 (p<0,001). Todos os sinais e sintomas melhoraram significativamente, e no primeiro dia de tratamento (p<0,001), com exceção da obstrução e secreção nasal, a partir do segundo dia (P<0,001). A frequência de eventos adversos foi 19,9 por cento, sendo 27,7 por cento na 1ª semana. CONCLUSÕES: A rupatadina é eficaz no controle da rinite alérgica persistente, é segura e apresenta baixos índices de efeitos colaterais.

Antibiotic use in post-adenotonsillectomy morbidity: a randomized prospective study.

UNLABELLED: Tonsillectomy with or without adenoidectomy still is one of the most commonly performed surgical procedures in the world, mostly in the pediatric population. AIM: to study the impact of amoxicillin for 7 days in post-adenotonsillectomy recovery, comparing results with a control group. STUDY TYPE: prospective, randomized, controlled study with 120 patients. PATIENTS AND METHODS: the patients were randomized according to surgery time to receive 7 days of amoxicillin associated with pain killers, or analgesic alone. During the first week of postoperative, we assessed the level of pain, oral intake acceptance, nausea and vomits, fever and return to daily activities. RESULTS: It was only in the fourth post-operative day that the group receiving antibiotic agents showed a statistically significant difference as far as pain is concerned. There was no difference between the two groups for other data analyzed. CONCLUSION: considering the results from our study and reviewing the literature on the use of antibiotic agents, we agree that there is no improvement in patient recovery after adenotonsillectomy with the use of amoxicillin for 7 days in the postoperative.

[Brainstem auditory evoked potentials as a method to assist the diagnosis of brain death]. / Potencial evocado auditivo de tronco encefálico como auxílio diagnóstico de morte encefálica.

BACKGROUND: brainstem auditory evoked potentials in brain death. AIM: to verify the agreement between the response in the auditory brainstem audiometry and the clinical outcome, analyzing the pattern of responses to electric stimulation. METHOD: a cross-sectional study performed in 30 patients with Glasgow coma score of 3, submitted to the auditory brainstem audiometry and followed up until their clinical outcome: recovery or death. The test was considered positive to brain death when there was no registry of waves or when there was only the registry of wave I; and negative when there were two or more waves, independently of their latencies. RESULTS: Among the patients who presented positive results for brain death (86.66%), all died; the only patient who recovered presented a negative result, indicating a specificity of 100%. Internal consistency of data was also observed, with an intraclass correlation coefficient of 0.562, obtained using the Cronbach s test; and a significant agreement between the test and the clinical outcome using the Kappa s test, with a confidence interval of 95% (K = 0.545; p = 0.015). CONCLUSION: in the present study, the brainstem auditory evoked potential demonstrated to be highly specific in death prediction of patients in Glasgow coma score of 3, and was useful in assisting the diagnosis of brain death.

Avaliação da antibioticoterapia na morbidade pós-adenotonsilectomia: estudo prospectivo randomizado / Antibiotic use in post-adenotonsillectomy morbidity: a randomized prospective study

A tonsilectomia, associada ou não à adenoidectomia, continua a ser um dos procedimentos cirúrgicos mais realizados mundialmente, incidindo principalmente sobre a população pediátrica. OBJETIVO: Investigar o impacto do uso da amoxacilina por 7 dias na recuperação pós adenoamigdalectomia, comparando os resultados com um grupo controle. Tipo de Estudo: Estudo prospectivo randomizado controlado com 120 pacientes. PACIENTES E MÉTODO: Os pacientes foram randomizados ao tempo da cirurgia para receber um curso de 7 dias de amoxacilina associada a analgésicos ou apenas analgésicos. Durante a primeira semana de pós-operatório foram avaliados o grau de dor, aceitação da via oral, náuseas e vômitos, febre e retorno às atividades. RESULTADOS: Somente no 4º pós-operatório o grupo recebendo antibiótico teve uma diferença estatística significante no grau de dor. Não houve diferença entre os dois grupos para outros dados analisados. CONCLUSÃO: Considerando os resultados do nosso estudo e revisando a literatura sobre o uso de antibióticos, nós concordamos que não há nenhuma melhora na recuperação dos pacientes submetidos à adenoamigdalectomia após o uso de amoxicilina por 7 dias.

Tonsillectomy with or without adenoidectomy still is one of the most commonly performed surgical procedures in the world, mostly in the pediatric population. AIM: to study the impact of amoxicillin for 7 days in post-adenotonsillectomy recovery, comparing results with a control group. Study type: prospective, randomized, controlled study with 120 patients. PATIENTS AND METHODS: the patients were randomized according to surgery time to receive 7 days of amoxicillin associated with pain killers, or analgesic alone. During the first week of postoperative, we assessed the level of pain, oral intake acceptance, nausea and vomits, fever and return to daily activities. RESULTS: It was only in the fourth post-operative day that the group receiving antibiotic agents showed a statistically significant difference as far as pain is concerned. There was no difference between the two groups for other data analyzed. CONCLUSION: considering the results from our study and reviewing the literature on the use of antibiotic agents, we agree that there is no improvement in patient recovery after adenotonsillectomy with the use of amoxicillin for 7 days in the postoperative.

Potencial evocado auditivo de tronco encefálico como auxílio diagnóstico de morte encefálica / Brainstem auditory evoked potentials as a method to assist the diagnosis of brain death

TEMA: Potencial Evocado Auditivo de Tronco Encefálico aplicado em morte encefálica. OBJETIVO: verificar a concordância entre o resultado do Potencial Evocado Auditivo de Tronco Encefálico e o desfecho do quadro clínico, em pacientes em coma Glasgow 3, por meio da análise do padrão de resposta elétrica do teste. MÉTODO: estudo tipo transversal realizado em 30 pacientes em coma Glasgow 3 submetidos ao Potencial Evocado Auditivo de Tronco Encefálico e acompanhados quanto ao desfecho clínico após o teste: recuperação ou óbito. O teste seria considerado positivo para morte encefálica ao registrar com reprodutibilidade ausência de todas as ondas ou presença de apenas a onda I, e considerado negativo na presença de duas ou mais ondas independentes de suas latências. RESULTADOS: entre os pacientes que apresentaram testes positivos para morte encefálica (86,66 por cento), todos foram a óbito e o único paciente que se recuperou apresentou teste negativo indicando especificidade de 100 por cento. Observou-se consistência interna dos dados, com coeficiente de correlação intraclasse de 0,562 por meio do Teste Alfa de Cronbach e concordância significativa entre o teste e o desfecho clínico por meio do Teste de Concordância de Kappa (K = 0,545; p = 0,015), com intervalo de confiança de 95 por cento. CONCLUSÃO: para o presente estudo o Potencial Evocado Auditivo de Tronco encefálico demonstrou ser um teste altamente específico na predição de óbito em pacientes em coma Glasgow 3, e possibilitou auxiliar o diagnóstico de morte encefálica.

BACKGROUND: brainstem auditory evoked potentials in brain death. AIM: to verify the agreement between the response in the auditory brainstem audiometry and the clinical outcome, analyzing the pattern of responses to electric stimulation. METHOD: a cross-sectional study performed in 30 patients with Glasgow coma score of 3, submitted to the auditory brainstem audiometry and followed up until their clinical outcome: recovery or death. The test was considered positive to brain death when there was no registry of waves or when there was only the registry of wave I; and negative when there were two or more waves, independently of their latencies. RESULTS: Among the patients who presented positive results for brain death (86.66 percent), all died; the only patient who recovered presented a negative result, indicating a specificity of 100 percent. Internal consistency of data was also observed, with an intraclass correlation coefficient of 0.562, obtained using the Cronbach´s test; and a significant agreement between the test and the clinical outcome using the Kappa´s test, with a confidence interval of 95 percent (K = 0.545; p = 0.015). CONCLUSION: in the present study, the brainstem auditory evoked potential demonstrated to be highly specific in death prediction of patients in Glasgow coma score of 3, and was useful in assisting the diagnosis of brain death.

Zumbido devido a alterações anatômicas de artéria basilar / Tinnitus due to anatomical alterations of basilar artery

O zumbido é um sintoma otoneurológico que afeta considerável parcela da população. Embora os mecanismos fisiopatológicos associados a ele não estejam completamente elucidados, é muito freqüente sua associação à perda auditiva. Alguns tipos de zumbido, entretanto, apresentam características peculiares, como o zumbido pulsátil. Esse pode ser causado por alterações vasculares congênitas, neoplásicas e traumáticas, dentre outras muitas. O presente estudo relata dois casos de pacientes com zumbido pulsátil, devido a alterações anatômicas de artéria basilar, sendo um com tortuosidade e outro megadolicobasilar, entidade pouco descrita na literatura. Em ambos os casos, pelas características causais associadas, que restringem o tratamento cirúrgico, optou-se pelo uso de clonazepan. Os pacientes apresentaram redução da sintomatologia durante o sono, principal queixa, permanecendo em acompanhamento ambulatorial.

Tinnitus is an otoneurological symptom that affects a considerable part of the population. Although pathophysiologicalmechanisms associated to this symptom are not completely disclosed, it is very common the association with hearing loss. Some kinds of tinnitus, however, can have specific characteristics, as a pulsatile tinnitus. It can be caused by vascular alterations, neoplasms or traumas, besides other pathologies. This paper reports two cases of patients with pulsatile tinnitus due to anatomical alterations of basilar artery; the first one due to an arterial deviousness and the second with a dolichomegabasilar, acondition rarely reported in literature. Due to the causal characteristics of this cases and the difficulties of surgicaltreatment, we prescribed clonazepam. The symptom did not disappear, but it was reduced during the sleep. The patients are being followed-up in our outpatient care unit nowadays.

Burning mouth syndrome: etiology.

The Burning Mouth Syndrome (BMS) is an oral mucosa pain--with or without inflammatory signs--without any specific lesion. It is mostly observed in women aged 40-60 years. This pain feels like a moderate/severe burning, and it occurs more frequently on the tongue, but it may also be felt at the gingiva, lips and jugal mucosa. It may worsen during the day, during stress and fatigue, when the patient speaks too much, or through eating of spicy/hot foods. The burning can be diminished with cold food, work and leisure. The goal of this review article is to consider possible BMS etiologies and join them in 4 groups to be better studied: local, systemic, emotional and idiopathic causes of pain. Knowing the different diagnoses of this syndrome, we can establish a protocol to manage these patients. Within the local pain group, we must investigate dental, allergic and infectious causes. Concerning systemic causes we need to look for connective tissue diseases, endocrine disorders, neurological diseases, nutritional deficits and salivary glands alterations that result in xerostomia. BMS etiology may be of difficult diagnosis, many times showing more than one cause for oral pain. A detailed interview, general physical examination, oral cavity and oropharynx inspection, and lab exams are essential to avoid a try and error treatment for these patients.

Tympanoplasty: surgical results and a comparison of the factors that may interfere in their success.

UNLABELLED: Chronic otitis media has a high prevalence on the population and their treatment continuous to be a challenge for the otorhinolaryngologists. AIM: To demonstrate the factors that could interfere in the tympanoplasty success and the surgical results during 2002. STUDY DESIGN: Clinical prospective. MATERIAL AND METHOD: were included 37 patients with chronic otitis media non cholesteatoma (COMNC) undergo to tympanoplasty (in lay or underlay, with homologous graft). All the patients were submitted to a survey pre and postoperative include clinical, physical examinations, flexible nasal endoscope and audiometry. RESULTS: The age, the dimension and localization of the tympanic membrane perforation; the condition of middle ear mucosa; number of otorrhea/year; smoking; parents history of otorrhea and hearing loss; personals history of otological surgery; monthly family income; the graft, technique and access used were not significantly to repair tympanic membrane perforations. The closure rate was 65% and the gain in air-bone gap was 100%. CONCLUSION: The timpanoplasty must be considerate in the treatment of the COMNC.

Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic acid in the treatment of upper respiratory tract infections in adults--an open-label, multicentric, randomized trial.

UNLABELLED: Upper respiratory tract infections are the most common causes of medical visits in children and adults, demanding massive use of antibiotics. Bacterial resistance caused by beta-lactamase is one of the most serious problems in this matter. Sultamicillin, a double pro-drug of Ampicillin/Sulbactan, is a potent beta-lactamase inhibitor which can face this challenge. AIM: Evaluate efficacy, safety and tolerability of Ampicillin/Sulbactan compared to Amoxicillin/Clavulanate in upper respiratory tract infections in adults. METHODS: 102 patients were enrolled and randomized to receive Ampicillin/Sulbactan or Amoxicillin/Clavulanate during 10 days. They were evaluated 10 and 30 days after treatment to learn about the therapeutic response. RESULTS: There were no differences between the two groups respecting cure at the end of treatment (visit 2) or at the end of the study (visit 3). Cure ratio was 61.7% and 93.2% (visits 2 and 3) in the Amoxicillin/Clavulanate group compared to 64.4% and 97.4%, respectively, in Ampicillin/Sulbactan group. The adverse events ratio for the two groups was the same (p=0.940). The number of patients with diarrhea was greater in the group of patients receiving Amoxicillin/Clavulanate (70.6%) than in the group receiving Ampicillin/Sulbactan (29.4%) (p=0.0164). CONCLUSIONS: Ampicillin/Sulbactan is as safe and efficient as Amoxicillin/Clavulanate in the empiric treatment of upper respiratory infections in adults. The low occurrence of diarrhea in the group receiving Ampicillin/Sulbactan needs confirmation in other studies.